Status: current, Defined. Date: 30-Apr 2014. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 866871000036116 | ranibizumab 1.65 mg / 0.165 mL injection, 0.165 mL syringe (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 866881000036119 | ranibizumab 1.65 mg/0.165 mL injection, syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| ranibizumab 1.65 mg/0.165 mL injection, syringe | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| ranibizumab 1.65 mg/0.165 mL injection, syringe | Is a | ranibizumab | true | Inferred relationship | Some | ||
| ranibizumab 1.65 mg/0.165 mL injection, syringe | has intended active ingredient | ranibizumab | true | Inferred relationship | Some | 811762776 | |
| ranibizumab 1.65 mg/0.165 mL injection, syringe | has Australian BoSS | ranibizumab | true | Inferred relationship | Some | 811762776 | |
| ranibizumab 1.65 mg/0.165 mL injection, syringe | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| ranibizumab 1.65 mg/0.165 mL injection, syringe | has unit of use | syringe | true | Inferred relationship | Some | 811762777 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lucentis 1.65 mg/0.165 mL injection, 0.165 mL syringe | Is a | True | ranibizumab 1.65 mg/0.165 mL injection, syringe | Inferred relationship | Some | |
| ranibizumab 1.65 mg/0.165 mL injection, 0.165 mL syringe | has MPUU | True | ranibizumab 1.65 mg/0.165 mL injection, syringe | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR